Initial public offering of up to 64,75,560 equity shares of face value of Rs. 10 each ("Equity Shares") of Iberia Pharmaceuticals India Limited (the "Company" or the "Issuer") for cash at a price of Rs.[*] per equity share including a share premium of Rs. [*] per equity share (the "Issue Price") aggregating up to Rs. [*] Crores ("the Issue"). The issue shall consists of [*]% of the post-issue paid-up equity share capital of the company. The face value of the equity shares is Rs. 10 each and the issue price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be decided by the company in consultation with the book running lead manager and will be advertised in all editions of the english national daily newspaper [*], all editions of the hindi national daily newspaper [*], and [*] edition of [*] (hindi also being the regional language of the state wherein the registered office of the company is located) each with wide circulation, at least two working days prior to the bid/issue opening date and shall be made available to stock exchanges for the purpose of uploading on their respective websites in accordance with the securities and exchange board of india ( Issue of Capital and Disclosure Requirements ) regulations, 2018 (the "sebi icdr regulations").
*subject to finalization of basis of allotment.